Turn Therapeutics (TTRX) Retained Earnings (2024 - 2026)

Turn Therapeutics' Retained Earnings history runs 3 years deep, the most recent figure standing at -$23.4 million for Q1 2026.

• On a quarterly basis, Retained Earnings changed N/A year-over-year to -$23.4 million in Q1 2026; TTM through Mar 2026 was -$23.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$22.4 million, down 16.64% from the prior year.
• Retained Earnings retreated to -$23.4 million in Q1 2026 per TTRX's latest filing, from -$22.4 million in the prior quarter.
• Across five years, Retained Earnings topped out at -$19.2 million in Q4 2024 and bottomed at -$23.4 million in Q1 2026.
• The 3-year median for Retained Earnings is -$22.5 million (2025), against an average of -$21.9 million.
• Biggest YoY gain for Retained Earnings was 16.64% in 2025; the steepest drop was 16.64% in 2025.
• Year by year, Retained Earnings stood at -$19.2 million in 2024, then slipped by 16.64% to -$22.4 million in 2025, then fell by 4.34% to -$23.4 million in 2026.
• Per Business Quant, the three latest TTRX Retained Earnings figures stand at -$23.4 million (Q1 2026), -$22.4 million (Q4 2025), and -$22.7 million (Q3 2025).